Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence

• Asıl Yazarlar: Ariana W. K. Katz (Yazar), Barbara S. Mensch (Yazar), Kubashni Woeber (Yazar), Petina Musara (Yazar), Juliane Etima (Yazar), Ariane van der Straten (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2019-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background In biomedical prevention trials, correct and consistent use of the investigational product is crucial to determine efficacy. Product adherence in VOICE, a phase 2B randomized trial of a vaginal gel and oral tablets for HIV prevention, was low (~ 34%), yet self-reported adherence...